A potent antimalarial activity of 5-fluoroorotate in combination with sulfamonomethoxine against Plasmodium falciparum in vitro and Plasmodium berghei in mice

Hye-Sook Kim, Hirofumi Miyake, Meiji Arai, Yusuke Wataya

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The antimalarial activity of 5-fluoroorotate and sulfamonomethoxine, 4- amino-N-(6-methoxy-4-pyrimidinyl) benzenesulfonamide, was evaluated against Plasmodium falciparum in vitro and P. berghei in vivo. The concentrations of 5-fluoroorotate and sulfamonomethoxine required for 50% inhibition of growth (IC50) of P. falciparum were 4.8 nM and 1.2 μM, respectively. In vitro, a combination of 5-fluoroorotate with sulfamonomethoxine showed potent synergy: the required concentrations in combination for 5-fluoroorotate and sulfamonomethoxine were as low as 1/12 and 1/15 of the respective IC50 values. In vivo, although either 5-fluoroorotate or sulfamonomethoxine given orally reduced parasitemia, neither completely eliminated parasites from mice. In contrast, a combination of 5-fluoroorotate and sulfamonomethoxine produced a rapid decrease in parasitemia within 24 h and achieved complete cure of mice, with no parasite recrudescence or toxicity. These results suggest that a combination of 5-fluoroorotate and sulfamonomethoxine could form the basis of a new antimalarial combination for the treatment of human malaria.

Original languageEnglish
Pages (from-to)59-67
Number of pages9
JournalParasitology International
Volume47
Issue number1
DOIs
Publication statusPublished - Mar 1 1998

Fingerprint

Sulfamonomethoxine
Plasmodium berghei
Antimalarials
Plasmodium falciparum
Parasitemia
Inhibitory Concentration 50
Parasites
In Vitro Techniques
Malaria

Keywords

  • 5- Fluoroorotate
  • Antimalarial agent
  • Combination chemotherapy
  • P. berghei
  • P. falciparum
  • Sulfamonomethoxine

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Cite this

A potent antimalarial activity of 5-fluoroorotate in combination with sulfamonomethoxine against Plasmodium falciparum in vitro and Plasmodium berghei in mice. / Kim, Hye-Sook; Miyake, Hirofumi; Arai, Meiji; Wataya, Yusuke.

In: Parasitology International, Vol. 47, No. 1, 01.03.1998, p. 59-67.

Research output: Contribution to journalArticle

@article{1d31e5e2c64a4543b7222d5771ae69b7,
title = "A potent antimalarial activity of 5-fluoroorotate in combination with sulfamonomethoxine against Plasmodium falciparum in vitro and Plasmodium berghei in mice",
abstract = "The antimalarial activity of 5-fluoroorotate and sulfamonomethoxine, 4- amino-N-(6-methoxy-4-pyrimidinyl) benzenesulfonamide, was evaluated against Plasmodium falciparum in vitro and P. berghei in vivo. The concentrations of 5-fluoroorotate and sulfamonomethoxine required for 50{\%} inhibition of growth (IC50) of P. falciparum were 4.8 nM and 1.2 μM, respectively. In vitro, a combination of 5-fluoroorotate with sulfamonomethoxine showed potent synergy: the required concentrations in combination for 5-fluoroorotate and sulfamonomethoxine were as low as 1/12 and 1/15 of the respective IC50 values. In vivo, although either 5-fluoroorotate or sulfamonomethoxine given orally reduced parasitemia, neither completely eliminated parasites from mice. In contrast, a combination of 5-fluoroorotate and sulfamonomethoxine produced a rapid decrease in parasitemia within 24 h and achieved complete cure of mice, with no parasite recrudescence or toxicity. These results suggest that a combination of 5-fluoroorotate and sulfamonomethoxine could form the basis of a new antimalarial combination for the treatment of human malaria.",
keywords = "5- Fluoroorotate, Antimalarial agent, Combination chemotherapy, P. berghei, P. falciparum, Sulfamonomethoxine",
author = "Hye-Sook Kim and Hirofumi Miyake and Meiji Arai and Yusuke Wataya",
year = "1998",
month = "3",
day = "1",
doi = "10.1016/S1383-5769(98)00003-8",
language = "English",
volume = "47",
pages = "59--67",
journal = "Parasitology International",
issn = "1383-5769",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - A potent antimalarial activity of 5-fluoroorotate in combination with sulfamonomethoxine against Plasmodium falciparum in vitro and Plasmodium berghei in mice

AU - Kim, Hye-Sook

AU - Miyake, Hirofumi

AU - Arai, Meiji

AU - Wataya, Yusuke

PY - 1998/3/1

Y1 - 1998/3/1

N2 - The antimalarial activity of 5-fluoroorotate and sulfamonomethoxine, 4- amino-N-(6-methoxy-4-pyrimidinyl) benzenesulfonamide, was evaluated against Plasmodium falciparum in vitro and P. berghei in vivo. The concentrations of 5-fluoroorotate and sulfamonomethoxine required for 50% inhibition of growth (IC50) of P. falciparum were 4.8 nM and 1.2 μM, respectively. In vitro, a combination of 5-fluoroorotate with sulfamonomethoxine showed potent synergy: the required concentrations in combination for 5-fluoroorotate and sulfamonomethoxine were as low as 1/12 and 1/15 of the respective IC50 values. In vivo, although either 5-fluoroorotate or sulfamonomethoxine given orally reduced parasitemia, neither completely eliminated parasites from mice. In contrast, a combination of 5-fluoroorotate and sulfamonomethoxine produced a rapid decrease in parasitemia within 24 h and achieved complete cure of mice, with no parasite recrudescence or toxicity. These results suggest that a combination of 5-fluoroorotate and sulfamonomethoxine could form the basis of a new antimalarial combination for the treatment of human malaria.

AB - The antimalarial activity of 5-fluoroorotate and sulfamonomethoxine, 4- amino-N-(6-methoxy-4-pyrimidinyl) benzenesulfonamide, was evaluated against Plasmodium falciparum in vitro and P. berghei in vivo. The concentrations of 5-fluoroorotate and sulfamonomethoxine required for 50% inhibition of growth (IC50) of P. falciparum were 4.8 nM and 1.2 μM, respectively. In vitro, a combination of 5-fluoroorotate with sulfamonomethoxine showed potent synergy: the required concentrations in combination for 5-fluoroorotate and sulfamonomethoxine were as low as 1/12 and 1/15 of the respective IC50 values. In vivo, although either 5-fluoroorotate or sulfamonomethoxine given orally reduced parasitemia, neither completely eliminated parasites from mice. In contrast, a combination of 5-fluoroorotate and sulfamonomethoxine produced a rapid decrease in parasitemia within 24 h and achieved complete cure of mice, with no parasite recrudescence or toxicity. These results suggest that a combination of 5-fluoroorotate and sulfamonomethoxine could form the basis of a new antimalarial combination for the treatment of human malaria.

KW - 5- Fluoroorotate

KW - Antimalarial agent

KW - Combination chemotherapy

KW - P. berghei

KW - P. falciparum

KW - Sulfamonomethoxine

UR - http://www.scopus.com/inward/record.url?scp=0031969322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031969322&partnerID=8YFLogxK

U2 - 10.1016/S1383-5769(98)00003-8

DO - 10.1016/S1383-5769(98)00003-8

M3 - Article

AN - SCOPUS:0031969322

VL - 47

SP - 59

EP - 67

JO - Parasitology International

JF - Parasitology International

SN - 1383-5769

IS - 1

ER -